➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
McKesson
Mallinckrodt
Express Scripts
AstraZeneca

Last Updated: July 27, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: pemigatinib


Email this page to a colleague

« Back to Dashboard

pemigatinib

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Incyte Corp PEMAZYRE pemigatinib TABLET;ORAL 213736 NDA Incyte Corporation 50881-026-01 14 TABLET in 1 BOTTLE, PLASTIC (50881-026-01) 2020-04-17
Incyte Corp PEMAZYRE pemigatinib TABLET;ORAL 213736 NDA Incyte Corporation 50881-027-01 14 TABLET in 1 BOTTLE, PLASTIC (50881-027-01) 2020-04-17
Incyte Corp PEMAZYRE pemigatinib TABLET;ORAL 213736 NDA Incyte Corporation 50881-028-01 14 TABLET in 1 BOTTLE, PLASTIC (50881-028-01) 2020-04-17
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Johnson and Johnson
McKesson
McKinsey
Dow